The Clinical Evaluation Report (CER) is a key requirement for CE Marking under EU MDR 2017/745. Accuprec’s Regulatory Affairs team specializes in preparing CERs that comply with MEDDEV 2.7/1 Rev. 4 and MDR Annex XIV, combining scientific literature, clinical data and performance evidence. :contentReference[oaicite:1]{index=1}

Our CER Development Process:

• Clinical Literature Review: Comprehensive data retrieval and evaluation using PubMed, Embase and other indexed databases. :contentReference[oaicite:2]{index=2}
• Clinical Data Evaluation: Assessment of preclinical, clinical and post-market data. :contentReference[oaicite:3]{index=3}
• Equivalence Assessment: Comparison of your device with predicate devices using structured equivalence tables. :contentReference[oaicite:4]{index=4}
• Risk–Benefit Analysis: Systematic evaluation of safety and performance outcomes. :contentReference[oaicite:5]{index=5}
• Gap Analysis & PMS Integration: Updating CERs with post-market surveillance and vigilance data. :contentReference[oaicite:6]{index=6}

Why Choose Accuprec

• Expertise in EU MDR technical documentation and notified body feedback handling. :contentReference[oaicite:7]{index=7}
• Multi-disciplinary CER team combining clinicians, toxicologists and regulatory experts. :contentReference[oaicite:8]{index=8}
• Support for initial submissions, renewals and periodic CER updates. :contentReference[oaicite:9]{index=9}

Outcome: Regulator-ready CERs ensuring compliance, traceability and market access in the EU region. :contentReference[oaicite:10]{index=10}